Scarica l'app Stockscreener
31.99
1.07%
0.34
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché VKTX Giù?
Forum
Previsione
Viking Therapeutics Inc Borsa (VKTX) Ultime notizie
Is Viking Therapeutics (VKTX) Quietly Recasting Its Metabolic Ambitions With VK2735 And New Leadership? - Yahoo Finance
Viking Therapeutics: A High-Stakes Bet on Clinical Success - AD HOC NEWS
Viking Therapeutics stock suffers worst day in over 4 months as top execs dump shares — Novo’s $149 Wegovy move looms - MSN
Has The Pullback In Viking Therapeutics (VKTX) Opened A New Valuation Opportunity - simplywall.st
Viking Therapeutics, Inc. (VKTX) Outperforms Broader Market: What You Need to Know - Yahoo Finance
VKTX Completes Enrollment in Phase I Maintenance Study of Obesity Drug - Yahoo Finance
Viking Therapeutics Stock Faces Pressure Amid Insider Sales - AD HOC NEWS
Viking Therapeutics completes enrollment in trial of VK2735 - Yahoo Finance
Viking Therapeutics Advances Obesity Drug Development and Commercial Strategy - AD HOC NEWS
Will Viking Therapeutics’ New CCO Reframe VKTX’s Obesity Strategy Amid Intensifying GLP-1 Competition? - Sahm
Can Viking Therapeutics Inc. stock maintain growth trajectoryJuly 2025 Snapshot & Real-Time Volume Trigger Notifications - ulpravda.ru
Viking Therapeutics: InvestingPro’s overvalued call proved right amid volatility By Investing.com - Investing.com Nigeria
Brokers Suggest Investing in Viking Therapeutics (VKTX): Read This Before Placing a Bet - Finviz
Brokers suggest investing in Viking Therapeutics (VKTX): Read this before placing a bet - MSN
How Viking Therapeutics Inc. stock performs during Fed tightening cyclesPortfolio Performance Summary & Free Daily Entry Point Trade Alerts - ulpravda.ru
Will Viking Therapeutics Inc. stock outperform growth indexes2025 Fundamental Recap & Low Drawdown Momentum Ideas - ulpravda.ru
Viking Therapeutics (VKTX) Completes Enrollment for Key Metaboli - GuruFocus
Viking Therapeutics completes enrollment in obesity drug maintenance study By Investing.com - Investing.com Australia
Viking Therapeutics completes enrollment in obesity drug maintenance study - Investing.com
Viking Therapeutics Announces Completion of Enrollment in Maintenance Dosing Clinical Trial of VK2735 in Obesity - PR Newswire
Viking Therapeutics Charts Commercial Course with Key Appointment and Upcoming Investor Presentation - AD HOC NEWS
Viking Therapeutics Faces Headwinds Amid Commercial Push and Insider Sales - AD HOC NEWS
Viking Therapeutics Stock Suffers Worst Day In Over 4 Months As Top Execs Dump Shares — Novo’s $149 Wegovy Move Looms - Stocktwits
Viking Therapeutics: A Tale of Strategic Hiring and Insider Sales - AD HOC NEWS
Viking Therapeutics Hires Neil Aubuchon as Chief Commercial Officer - Contract Pharma
Viking Therapeutics appoints Neil Aubuchon as chief commercial officer By Investing.com - Investing.com Nigeria
Viking Therapeutics appoints Neil Aubuchon as chief commercial officer - Investing.com India
Viking Therapeutics Announces Appointment of Neil Aubuchon as Chief Commercial Officer - PR Newswire
Why Viking Therapeutics Stock Crashed Today - AOL.com
Viking Therapeutics (VKTX) Valuation Check After Recent Share Price Weakness - Yahoo Finance
Viking Therapeutics Faces Scrutiny Amid Insider Sales and Key Industry Event - AD HOC NEWS
Here's How Much $100 Invested In Viking Therapeutics 10 Years Ago Would Be Worth Today - Sahm
Here's What $100 Invested in Viking Therapeutics a Decade Ago Would Amount to Now - Bitget
Examining the Latest Short Interest in Viking Therapeutics Inc - Bitget
Looking Into Viking Therapeutics Inc's Recent Short Interest - Sahm
Insider Sales and Market Competition Weigh on Viking Therapeutics Shares - AD HOC NEWS
Insider Sell Alert: Matthew Foehr Sells 16,000 Shares of Viking Therapeutics Inc (VKTX) - GuruFocus
Viking Therapeutics Insider Sold Shares Worth $7,692,121, According to a Recent SEC Filing - MarketScreener
Viking Therapeutics Insider Sold Shares Worth $1,896,969, According to a Recent SEC Filing - MarketScreener
Leadership Stock Sales Cast Shadow Over Viking Therapeutics’ Prospects - AD HOC NEWS
What drives Viking Therapeutics Inc 1VT stock pricePrice Action Analysis & Low Risk Wealth Building - earlytimes.in
Insider Selling: Viking Therapeutics (NASDAQ:VKTX) CEO Sells 233,409 Shares of Stock - MarketBeat
Viking Therapeutics (NASDAQ:VKTX) CFO Sells $1,897,046.90 in Stock - MarketBeat
Marianna Mancini Sells 57,661 Shares of Viking Therapeutics (NASDAQ:VKTX) Stock - MarketBeat
Viking Therapeutics CEO Lian sells $7.69m in shares By Investing.com - Investing.com Nigeria
Viking therapeutics COO Mancini sells $1.9 million in stock By Investing.com - Investing.com Nigeria
Viking Therapeutics CEO Lian sells $7.69m in shares - Investing.com
Viking therapeutics COO Mancini sells $1.9 million in stock - Investing.com
Viking Therapeutics director Foehr sells $561,694 in shares By Investing.com - Investing.com South Africa
Viking Therapeutics director Foehr sells $561,694 in shares - Investing.com
Viking therapeutics CFO Zante sells $1.89m in shares By Investing.com - Investing.com UK
A Look At Viking Therapeutics (VKTX) Valuation As Long Term Gains Contrast Recent Losses - simplywall.st
Viking Therapeutics, Inc. (VKTX) Stock Drops Despite Market Gains: Important Facts to Note - sharewise.com
Viking Therapeutics (NASDAQ:VKTX) Trading Down 6.1%What's Next? - MarketBeat
Viking Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference - WV News
Viking Therapeutics stock sinks as Novo’s Wegovy pill debut resets obesity-drug pricing - TechStock²
$VKTX stock is down 10% today. Here's what we see in our data. - Quiver Quantitative
0.90%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):